PAPAVERINE News
PAPAVERINE currently has 2 news articles, with 15 predicted indications.
This page combines the AI-predicted indications for PAPAVERINE with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (15):
- intermittent vascular claudication (99.0%)
- peripheral vascular disease (99.0%)
- transient ischemic attack (disease) (99.0%)
- peripheral arterial disease (99.0%)
- brain ischemia (99.0%)
- ischemic disease (99.9%)
- intracranial arteriosclerosis (99.9%)
- non-inflammatory vasculopathy (99.8%)
- vascular ectasia (99.8%)
- fibrocartilaginous embolism (99.8%)
- venous thromboembolism (99.8%)
- vascular insufficiency disorder (99.8%)
- angiodysplasia (99.8%)
- Raynaud disease (99.8%)
- Monckeberg arteriosclerosis (99.8%)
Related News (2)
From wrist to research: Harnessing smartwatch data for equitable cardiovascular research
2026-09-28 cardiovascular
Source: journals.plos.org
Conference MDAngle: HFSA 2026 Amyloidosis/ATTR-CM
2026-09-28 heart disease
Source: Medscape
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.